Developmental Funds
Developmental Funds
批准号:
8340234
负责人:
KEVIN J. CULLEN
金额:
$12.31万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-24 至 2016-07-31
关键词:
American Cancer SocietyAreaAwardBudgetsCancer Center Support GrantCancer Grant Supplements (P30)DevelopmentDirect CostsDisciplineEpidemiologyFacultyFundingFunding MechanismsGrantIceImageInterdisciplinary StudyInvestmentsLeadershipMarylandPainPeer ReviewPilot ProjectsProcessRecruitment ActivityReportingResearchResearch PersonnelScientistServicesSite VisitStrategic PlanningUnited States National Institutes of HealthUniversitiesbasehigh throughput screeningmeetingsmolecular pathologyprogramsranpirnase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
7.5.1 Overall Description
UMGCC requests developmental funds amounting to $260,000, or 9 percent of the total direct costs of its budget. These funds are essential for UMGCC to:
¿ Pilot projects for Developing Pain Studies Program ($50,000)
¿ Provide funds to support the establishment of three new developing shared sen/ices ($60,000)
¿ Fund five new pilot projects for Shared Services annually ($50,000)
¿ Conduct recruiting for epidemiology ($100,000)
Developmental funds will be necessary for UMGCC's leadership to recruit faculty in high-priority areas established by the strategic planning process. In addition, the promotion of Interdisciplinary research will require seed money for pilot grant support in areas that bring investigators of different disciplines together and utilize UMGCC's shared services. Finally, core grant support will be necessary for further establishing essential shared services, such as imaging, molecular pathology, and high-throughput screening. Developmental funds from the P30 Grant will continue to be leveraged by additional funds from Maryland's CRFP and the American Cancer Society (ACS) over the next 5 years. Allocation of developmental funds will be through (a) the
strategic-planning process internal to UMGCC, with peer review and approval of the UMGCC Research Council; and (b) recruitment in predefined areas that meet the criteria established by senior leadership. The 2008 NCI Site Visit Report gave this section an Excellent to Very Good rating. NCI thought that requests were well justified and the monies would augment the substantial investment that UMGCC had made in developing programs and shared services. NCI noted the description of the planned usage of these combined investments lacked adequate focus and prioritization of two developing programs and four additional shared services.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting PI3Kalpha beta and the ErbB family of protein-tyrosine kinases in cisplatin-resistant head and neck squamous cell carcinomas (HNSCC)
-
批准号:10667253
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2022
-
负责人:KEVIN J. CULLEN
-
依托单位:
Program Leaders of Research Programs
-
批准号:8711295
-
项目类别:
-
资助金额:$8.21万
-
财政年份:2014
-
负责人:KEVIN J. CULLEN
-
依托单位:
Cancer Center Administration
-
批准号:8711298
-
项目类别:
-
资助金额:$9.74万
-
财政年份:2014
-
负责人:KEVIN J. CULLEN
-
依托单位:
Program Leaders
-
批准号:8340231
-
项目类别:
-
资助金额:$8.47万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
Genomics - Shared Services
-
批准号:8340237
-
项目类别:
-
资助金额:$11.4万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
Radiation Linear Shared Service
-
批准号:8340240
-
项目类别:
-
资助金额:$8.14万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
Pathology and Biorepository
-
批准号:8340242
-
项目类别:
-
资助金额:$6.67万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
Structural Biology
-
批准号:8340243
-
项目类别:
-
资助金额:$7.15万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
Proteomics
-
批准号:8340248
-
项目类别:
-
资助金额:$6.71万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
Biostatistics Shared Service
-
批准号:8340238
-
项目类别:
-
资助金额:$14.47万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
Flow Cytometry
-
批准号:8340241
-
项目类别:
-
资助金额:$5.31万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
Clinical Research Shared Services
-
批准号:8340249
-
项目类别:
-
资助金额:$12.82万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
Protocol Specific Research
-
批准号:8340252
-
项目类别:
-
资助金额:$7.12万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
Planning and Evaluation
-
批准号:8340232
-
项目类别:
-
资助金额:$4.1万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
Translational Laboratory
-
批准号:8340247
-
项目类别:
-
资助金额:$6.93万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
Protocol Review and Monitoring System
-
批准号:8340250
-
项目类别:
-
资助金额:$6.06万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
Data and Safety Monitoring
-
批准号:8340253
-
项目类别:
-
资助金额:$6.16万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
Animals Shared Service
-
批准号:8340239
-
项目类别:
-
资助金额:$10.27万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
Senior Leadership
-
批准号:8340230
-
项目类别:
-
资助金额:$12.57万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
Administration
-
批准号:8340235
-
项目类别:
-
资助金额:$9.85万
-
财政年份:2011
-
负责人:KEVIN J. CULLEN
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: